The Catalyst Award will expedite the hunt for a validated test-to-treat model for ME/CFS, a disease for which there is currently no FDA-approved treatment. LOS ANGELES, June 17, 2025 /PRNewswire/ -- ...
People who often experience overwhelming fatigue, unrefreshing sleep, cognitive difficulties, pain, and a variety of autonomic and sensory disturbances may be suffering from myalgic ...
Solve ME/CFS Initiative’s (Solve M.E.) Catalyst Awards provide targeted funding to help studies in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), Long COVID, and related ...
New Catalyst Award funds high-impact research by Dr. Akiko Iwasaki, accelerating breakthroughs for millions. Solve M.E. is a national nonprofit dedicated to making myalgic encephalomyelitis/chronic ...
The Solve ME/CFS Catalyst Award-winning studies will fast-track clinical and immunological studies aimed at delivering new treatment strategies and diagnostic insights for ME/CFS and Long Covid, ...
LOS ANGELES, April 8, 2024 /PRNewswire/ -- Solve M.E., the leading organization dedicated to advancing medical research and patient advocacy since 1987, is pleased to announce that Emily Taylor, Vice ...
DELAFIELD, WI, UNITED STATES, August 13, 2025 /EINPresswire.com/ -- The Brain Inflammation Collaborative (BIC), in partnership with Solve M.E., is excited to announce ...
LOS ANGELES, April 29, 2025 /PRNewswire/ -- Solve M.E., the Brain Inflammation Collaborative (BIC), ChronicleBio, the Complex Disorders Alliance, and CareEvolution have launched a powerful new ...
The MarketWatch News Department was not involved in the creation of this content. The Solve ME/CFS Catalyst Award-winning studies will fast-track clinical and immunological studies aimed at delivering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results